Gene expression analysis of Fmr1-KO mouse caudate putamen reveals new preclinical biomarkers for fragile X syndrome

Shirin Sharghi, Stefanie Flunkert, Magdalena Daurer, Livia Breznik, Boris Philippe Chagnaud, Manuela Prokesch

Open source

DOI
10.3389/fnins.2026.1833413
Published
2026-10-23
Container
Frontiers in Neuroscience
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnins.2026.1833413,
  title = {Gene expression analysis of Fmr1-KO mouse caudate putamen reveals new preclinical biomarkers for fragile X syndrome},
  author = {Shirin Sharghi and Stefanie Flunkert and Magdalena Daurer and Livia Breznik and Boris Philippe Chagnaud and Manuela Prokesch},
  year = {2026},
  journal = {Frontiers in Neuroscience},
  doi = {10.3389/fnins.2026.1833413},
  url = {https://doi.org/10.3389/fnins.2026.1833413}
}

RIS

TY  - JOUR
TI  - Gene expression analysis of Fmr1-KO mouse caudate putamen reveals new preclinical biomarkers for fragile X syndrome
AU  - Shirin Sharghi
AU  - Stefanie Flunkert
AU  - Magdalena Daurer
AU  - Livia Breznik
AU  - Boris Philippe Chagnaud
AU  - Manuela Prokesch
PY  - 2026
JO  - Frontiers in Neuroscience
DO  - 10.3389/fnins.2026.1833413
UR  - https://doi.org/10.3389/fnins.2026.1833413
ER  - 

APA

Sharghi, S., Flunkert, S., Daurer, M., Breznik, L., Chagnaud, B. P., & Prokesch, M. (2026). Gene expression analysis of Fmr1-KO mouse caudate putamen reveals new preclinical biomarkers for fragile X syndrome. Frontiers in Neuroscience. https://doi.org/10.3389/fnins.2026.1833413

Source records